bmiMD vs RXSpan: NAD+ Therapy Compared
bmiMD starts at $89/mo (annual plan) and offers injection + nasal spray, while RXSpan starts at ~$249 (recurring) with not disclosed. Below we line them up on price, delivery formats, dosing, shipping, and overall value so you can see which prescription NAD+ provider fits you best.
- Physician-Prescribed Only
- 22 Providers Compared
- Results in 2–4 Weeks
bmiMD
From $89/mo (annual). Plans from $89–$119/mo. Free shipping. Full refund if not approved.
Visit bmiMD →RXSpan
NAD+ treatment starting at approximately $249. Online medical consultation included; recurring billing shown before checkout.
Visit RXSpan →| Feature | bmiMD | RXSpan |
|---|---|---|
| Editorial score | 9.31 / 10 | 8.40 / 10 |
| Starting price | $89/mo (annual plan) | ~$249 (recurring) |
| Renewal / ongoing | $99–$119/mo on shorter terms | Recurring; shown before checkout |
| Delivery formats | Injection + nasal spray | Not disclosed |
| Dose strengths | Nasal 300mg/mL; injection per protocol | Not disclosed |
| Shipping | Free | Not stated |
| Membership / fees | None | None |
| Guarantee | Full refund if not approved | — |
| Best for | People who want affordable injectable NAD+ with a no-risk approval guarantee | People who want a physician-consulted NAD+ plan with clear recurring billing before checkout |
Where bmiMD stands out
- + Lower entry price — $89/mo (annual plan)
- + More delivery formats — injection + nasal spray
- + Backed by a full refund if not approved
- + Higher editorial score (9.31 vs 8.40)
Where RXSpan stands out
RXSpan is closely matched with bmiMD on the headline metrics — the deciding factors come down to delivery format and the specifics below.
Pros & cons, side by side
bmiMD
Pros
- + Starts at $89/mo on annual plan — lowest price available
- + Flexible plans: monthly, quarterly, 6-month, or annual
- + Free shipping included
- + No-approval refund guarantee
Cons
- − Compounded medications — not FDA-approved finished products
RXSpan
Pros
- + Online medical consultation included
- + Recurring billing shown before checkout
- + Fully online process
Cons
- − Higher starting price than many competitors
- − Compounded NAD+ — not an FDA-approved finished product
The verdict: bmiMD vs RXSpan
In our editorial ranking, bmiMD places higher (#5 vs #21), making it the default pick for most readers — it's best for people who want affordable injectable NAD+ with a no-risk approval guarantee. That said, RXSpan is the stronger choice for people who want a physician-consulted NAD+ plan with clear recurring billing before checkout. Both are prescription NAD+ services, so the right answer depends on the delivery format and price structure that match how you want to start.
More head-to-head comparisons
Pricing and product details were verified against each provider's official pages and may change — always confirm current terms on the provider's site. Rx required; a licensed provider determines whether NAD+ therapy is appropriate for you. We may earn a commission from links on this page, which never affects our rankings.